Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/1999
03/11/1999WO1998056771A3 Piperazine derivatives and their use as anti-inflammatory agents
03/11/1999WO1998052937A3 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
03/11/1999WO1998051672A3 A method for the preparation of tertiary amines, a compound useful therefor and alpha-2-receptor active tetrahydroisoquinoline derivatives
03/11/1999WO1998050346A3 Acetamide and urea derivatives, process for their preparation and their use in the treatment of cns disorders
03/11/1999WO1998041513A3 Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof
03/11/1999DE19739638A1 Substituierte Phenyluracile Substituted Phenyluracils
03/11/1999CA2302161A1 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both
03/11/1999CA2301520A1 Pyrazinone thrombin inhibitors
03/10/1999EP0900795A1 Benzene derivatives substituted by heterocycles and herbicides
03/10/1999EP0900794A1 Light stabilizers based on sterically hindered amines
03/10/1999EP0900793A1 Cycloalkylaminomethylpyrrolidine derivatives
03/10/1999EP0900792A1 Piperazine and piperidine derivatives as 5-HT1 receptor agonists
03/10/1999EP0900791A1 Tetrazole derivatives and drugs containing the same as the active ingredient
03/10/1999EP0900789A2 Substituted quinolone derivatives and pharmaceuticals containing the same
03/10/1999EP0900568A2 AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
03/10/1999EP0900224A1 Propagylglycine derivatives, preparation and utilisation thereof as synthesis intermediates
03/10/1999EP0900218A1 Heterocyclic compounds
03/10/1999EP0900215A1 N-3 substituted pyrimidin-4-ones with aii antagonistic activity
03/10/1999EP0900214A1 Process for preparation of pyrimidine derivatives
03/10/1999EP0900208A1 Acyl mercapto-triazolyl derivatives and the use thereof as microbicides
03/10/1999EP0900207A1 Pyrazinone thrombin inhibitors
03/10/1999EP0900205A1 Pyrazole compounds, processes for their production and herbicides containing them
03/10/1999EP0900203A1 Quinoline derivatives, processes for their preparation, and their use as medicaments
03/10/1999EP0900083A1 Novel substituted imidazole compounds
03/10/1999EP0900081A1 Inhibitors of farnesyl-protein transferase
03/10/1999CN1210533A Quinolonecarboxylic acid derivatives or salts thereof
03/10/1999CN1210522A 2,4-diamino-1,3,5-iriazines, processes for their preparation and their use as herbicides and plant-growth regulators
03/10/1999CN1210521A Isoquinoline derivatives and drugs
03/10/1999CN1210517A Hydroxamic acid derivatives for use with treatment of diseases related to connective tissue degradation
03/10/1999CN1210106A Recovery of 2,2'-combined dipyridine of atom transferred free radical polymeris
03/10/1999CN1210105A Process for preparation of 2,5-disubstituted pyridines
03/10/1999CN1042423C Ameilazole salt hydrate for gastric acid inhibitor and its preparation
03/10/1999CN1042421C Preparation of acridine derivatives
03/09/1999US5880295 Process for the preparation of diamine intermediates useful in the synthesis of HIV protease inhibitors
03/09/1999US5880284 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
03/09/1999US5880283 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same
03/09/1999US5880141 Controlling, modulating and inhibiting tyrosine kinase signal transduction
03/09/1999US5880140 Biheteroaryl inhibitors of farnesyl-protein transferase
03/09/1999US5880139 Treating diabetes, obesity, hypertension, cachexia
03/09/1999US5880138 Antagonists of excitatory amino acids
03/09/1999US5880136 Sulfonamide fibrinogen receptor antagonists
03/09/1999US5880128 Inhibit abnormal growth of cells
03/09/1999US5879708 Stabilized pharmaceutical composition
03/09/1999US5879657 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
03/05/1999CA2246588A1 Improved process for the preparation of unsymmetrical 4,6-bis (aryloxy) pyrimidine compounds
03/04/1999WO1999010525A1 A method of treating cancer
03/04/1999WO1999010524A1 A method of treating cancer
03/04/1999WO1999010523A1 A method of treating cancer
03/04/1999WO1999010344A1 Indole derivatives as 5-ht1b and 5-ht1d agonists
03/04/1999WO1999010340A1 Compounds possessing neuronal activity
03/04/1999WO1999010339A1 2-aminopyridines containing fused ring substituents as nos inhibitors
03/04/1999WO1999010338A2 Benzylidene- and cinnamylidene-anabaseines as neuronal nicotinic alpha-7 receptor agonists
03/04/1999WO1999010331A1 Arylpyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors
03/04/1999WO1999010328A1 Heterocyclic substituted 4-benzoyl-pyrazole as herbicides
03/04/1999WO1999010325A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
03/04/1999WO1999010316A1 3-amidinoaniline derivatives, activated blood coagulation factor x inhibitors, and intermediates for producing both
03/04/1999WO1999010313A1 N-aroylphenylalanine derivatives
03/04/1999WO1999010312A1 N-alkanoylphenylalanine derivatives
03/04/1999WO1999010000A1 Combined preparations for treating upper gastrointestinal tract distress
03/04/1999WO1999009987A1 Method for treating premenstrual or late luteal phase syndrome
03/04/1999WO1999009984A1 Pyrrolidine and piperidine modulators of chemokine receptor activity
03/04/1999WO1998019648A3 N-oxy-naphthalimides as antibacterial agents
03/04/1999CA2301880A1 A method of treating cancer
03/04/1999CA2301877A1 A method of treating cancer
03/04/1999CA2301857A1 A method of treating cancer
03/04/1999CA2301750A1 Indole derivatives as 5-ht1b and 5-ht1d agonists
03/04/1999CA2301559A1 3-amidinoaniline derivatives, activated blood coagulation factor x inhibitors, and intermediates for producing both
03/04/1999CA2300134A1 Compounds possessing neuronal activity
03/04/1999CA2300121A1 N-alkanoylphenylalanine derivatives
03/04/1999CA2298979A1 Method for treating premenstrual or late luteal phase syndrome
03/04/1999CA2298813A1 Pyrrolidine and piperidine modulators of chemokine receptor activity
03/04/1999CA2245755A1 2-(arylphenyl)amino-imidazoline derivatives
03/03/1999EP0899295A1 Polycarbonate compositions comprising hindered amine light stabilizers
03/03/1999EP0899268A2 Process for the preparation of omeprazole and intermediate compounds
03/03/1999EP0899263A2 Fused pyrimidine derivatives and medicaments thereof for a blood oxygen partial pressure amelioration
03/03/1999EP0899262A2 Process for the preparation of heteroarylcarboxylic amides and esters
03/03/1999EP0899261A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists
03/03/1999EP0898963A2 Congestive heart failure treatment
03/03/1999EP0898569A1 Piperidines and pyrrolidines
03/03/1999EP0898568A1 1-(4-piperidyl)-benzimidazoles having neurotrophic activity
03/03/1999EP0898562A1 Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation
03/03/1999EP0777666B1 Substituted piperidines useful for the treatment of allergic diseases
03/03/1999EP0674641B1 Pyrrolopyrimidines as crf antagonists
03/03/1999EP0605697B1 Indol derivatives for the treatment of migraine
03/03/1999CN1209807A 1-pyrazol-3-yl-ethyl-4-indol-3-yl piperdine as medicine acting on central nervous system
03/03/1999CN1209805A Noval fused pyrrolecarboxamides and new class of GABA brain receptor ligands
03/03/1999CN1209803A Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method therefor
03/03/1999CN1209744A Vitronectin receptor antagonists
03/03/1999CN1209446A Polycarbonate composition containing hindered amine light stabilizing agent
03/03/1999CN1042335C 1-acylpiperidine compounds, preparation method, medicinal composition and use thereof
03/03/1999CN1042333C 5,6-disubstituted-3-pyridinemethyl ammonium halide compounds and preparation method therefor
03/03/1999CN1042289C Herbicidal composition containing pyridineamide derivative and use thereof
03/02/1999US5877329 Coupling/ring closure of a 2-halo or 2-trifluoromethylsulfonyloxy aniline and an alkyl ketone, indomethacin precursors
03/02/1999US5877321 Neurokinin receptor
03/02/1999US5877200 Cyclic amides
03/02/1999US5877199 Heterocyclic compounds, their preparation and their therapeutic use
03/02/1999US5877192 Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
03/02/1999US5877187 Benzimidazole derivatives with antihistaminic activity
03/02/1999US5877182 Piperidines promote release of growth hormone
03/02/1999US5877181 Benzamidine derivatives and their use as anti-coagulants
1 ... 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 ... 1080